Nonclinical Testing of Orally Inhaled Nicotine-Containing Drug Products Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
October 28, 2020
October 28, 2020
0ffdae5e-74df-4de2-b513-31064caf444d
Related Documents
Safety Testing of Drug Metabolites
Guidance DocumentNovember 22, 2016Center for Drug Evaluation and Research
Osteoporosis: Nonclinical Evaluation of Drugs Intended for Treatment Guidance for Industry: Guidance for Industry
Guidance DocumentAugust 15, 2019Center for Drug Evaluation and Research
Community-Acquired Bacterial Pneumonia: Developing Drugs for Treatment
Guidance DocumentJanuary 10, 2014Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox